Cytotoxic and antiproliferative effects of the nonsteroidal anti-inflammatory drug diclofenac in human tumour cell lines

References

• IQVIA 2020. Market Segmentation, MAT; Apr 2020. Available from: www.iqvia.com.
   Google Scholar
• Brogden R, Heel R, Pakes G, et al. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs. 1980;20(1):24–48.
   PubMed Web of Science ®Google Scholar
• Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715–1731.
   PubMed Web of Science ®Google Scholar
• Alfaro RA, Davis DD. Diclofenac. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Ghanghas P, Jain S, Rana C, et al. Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer. Biomed Pharmacother. 2016;78:239–247.
   PubMed Web of Science ®Google Scholar
• Cha YI, RN. DuBois NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med. 2007;58:239–252.
   PubMed Web of Science ®Google Scholar
• Pantziarka P, Sukhatme V, Bouche G, et al. Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience. 2016;10:610.
   PubMed Web of Science ®Google Scholar
• Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008;11(2):81s–110s.
   PubMed Web of Science ®Google Scholar
• Gunaydin C, Bilge SS. Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J Med. 2018;50(2):116–121.
   PubMed Web of Science ®Google Scholar
• Dermond O, Rüegg C. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives. Drug Resist Updat. 2001;4(5):314–321.
   PubMed Web of Science ®Google Scholar
• Zappavigna S, Cossu AM, Grimaldi A, et al. Anti-inflammatory drugs as anticancer agents. IJMS. 2020;21(7):2605.
   Google Scholar
• Hashemi Goradel N, Najafi M, Salehi E, et al. Cyclooxygenase-2 in cancer: a review. J Cell Physiol. 2019;234(5):5683–5699.
   PubMed Web of Science ®Google Scholar
• Wang X, Baek SJ, Eling T. COX inhibitors directly alter gene expression: role in cancer prevention?Cancer Metastasis Rev. 2011;30(3–4):641–657.
   PubMed Web of Science ®Google Scholar
• Tangrea JA, Albert PS, Lanza E, et al. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control. 2003;14(5):403–411.
   PubMed Web of Science ®Google Scholar
• Díaz-Rodríguez L, García-Martínez O, Morales MA, et al. Effects of indomethacin, nimesulide, and diclofenac on human MG-63 osteosarcoma cell line. Biol Res Nurs. 2012;14(1):98–107.
   PubMed Web of Science ®Google Scholar
• Gottfried E, Lang SA, Renner K, et al. New aspects of an old drug-diclofenac targets MYC and glucose metabolism in tumor cells. PLoS One. 2013;8(7):e66987.
   PubMed Web of Science ®Google Scholar
• Hixson LJ, Alberts DS, Krutzsch M, et al. Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev. 1994;3(5):433–438.
   PubMed Web of Science ®Google Scholar
• Arisan ED, Ergül Z, Bozdağ G, et al. Diclofenac induced apoptosis via altering PI3K/Akt/MAPK signaling axis in HCT 116 more efficiently compared to SW480 colon cancer cells. Mol Biol Rep. 2018;45(6):2175–2184.
   PubMed Web of Science ®Google Scholar
• Al-Nimer MS, Hameed HG, Mahmood MM. Antiproliferative effects of aspirin and diclofenac against the growth of cancer and fibroblast cells: in vitro comparative study. Saudi Pharm J. 2015;23(5):483–486.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.
   PubMed Web of Science ®Google Scholar
• Nikolova I, Marinov L, Georgieva A, et al. Metamizole (dipyrone) - cytotoxic and antiproliferative effects on HeLa, HT-29 and MCF-7 cancer cell lines. Biotechnol Biotechnol Equip. 2018;32(5):1327–1337.
   Web of Science ®Google Scholar
• Sudsai T, Wattanapiromsakul C, Nakpheng T, et al. Evaluation of the wound healing property of Boesenbergia longiflora rhizomes. J Ethnopharmacol. 2013;150(1):223–231.
   PubMed Web of Science ®Google Scholar
• Arisan ED, Akar RO, Rencuzogullari O, et al. The molecular targets of diclofenac differs from ibuprofen to induce apoptosis and epithelial mesenchymal transition due to alternation on oxidative stress management p53 independently in PC3 prostate cancer cells. Prostate Int. 2019;7(4):156–165.
   PubMed Web of Science ®Google Scholar
• Yang L, Li J, Li Y, et al. Diclofenac impairs the proliferation and glucose metabolism of triple‑negative breast cancer cells by targeting the c‑Myc pathway. Exp Ther Med. 2021;21(1):1–9.
   PubMedGoogle Scholar
• Yagi K, Kawasaki Y, Nakamura H, et al. Differential combined effect of COX inhibitors on cell survival suppressed by sorafenib in the HepG2 cell line. Biol Pharm Bull. 2014;37(7):1234–1240.
   PubMed Web of Science ®Google Scholar
• Leidgens V, Seliger C, Jachnik B, et al. Ibuprofen and diclofenac restrict migration and proliferation of human glioma cells by distinct molecular mechanisms. PLoS One. 2015;10(10):e0140613.
   PubMed Web of Science ®Google Scholar
• Chirasani SR, Leukel P, Gottfried E, et al. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. Int J Cancer. 2013;132(4):843–853.
   PubMed Web of Science ®Google Scholar
• Zerbini LF, Tamura RE, Correa RG, et al. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy. PLoS One. 2011;6(9):e24285.
   PubMed Web of Science ®Google Scholar
• Valle BL, D’Souza T, Becker KG, et al. Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells. PLoS One. 2013;8(4):e61836.
   PubMed Web of Science ®Google Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516.
   PubMed Web of Science ®Google Scholar
• Gomez-Lechon MJ, Ponsoda X, O’Connor E, et al. Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochem Pharmacol. 2003;66(11):2155–2167.
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Komatsu H, Sumichika H, et al. Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells. Eur J Pharmacol. 1999;383(3):331–337.
   PubMed Web of Science ®Google Scholar
• Hickey EJ, Raje RR, Reid VE, et al. Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med. 2001;31(2):139–152.
   PubMed Web of Science ®Google Scholar
• García-Martínez JM, Fresno Vara JA, Lastres P, et al. Effect of metamizol on promyelocytic and terminally differentiated granulocytic cells: comparative analysis with acetylsalicylic acid and diclofenac. Biochem Pharmacol. 2003;65(2):209–217.
   PubMed Web of Science ®Google Scholar
• Inoue A, Muranaka S, Fujita H, et al. Molecular mechanism of diclofenac-induced apoptosis of promyelocytic leukemia: dependency on reactive oxygen species, Akt, Bid, cytochrome and caspase pathway. Free Radic Biol Med. 2004;37(8):1290–1299.
   PubMed Web of Science ®Google Scholar
• Albano F, Arcucci A, Granato G, et al. Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines. Biochimie. 2013;95(4):934–945.
   PubMed Web of Science ®Google Scholar
• Seliger C, Leukel P, Moeckel S, et al. Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro. PLoS One. 2013;8(11):e78935.
   PubMed Web of Science ®Google Scholar